The FDA has approved Emblaveo with metronidazole for patients with complicated intra-abdominal infections and limited options.

Forty percent of children undergoing CT for blunt abdominal trauma have incidental findings, but few require urgent care, a study finds.

Deborah Lowe, a 60-year-old from Milwaukee, filed a lawsuit after learning a feeding tube was left inside her body when she ...

AbbVie said on Friday that the U.S. Food and Drug Administration approved its drug for complicated intra-abdominal infections, including those caused by drug-resistant bacteria. AbbVie and ...

NORTH CHICAGO, Ill. - The U.S. Food and Drug Administration (FDA) has approved EMBLAVEO™ (aztreonam and avibactam) for the treatment of adults with complicated intra-abdominal infections (cIAI) with ...

People with Crohn’s disease who have had a previous abdominal surgery may be more prone to developing adhesions. Adhesions can also develop from an abscess or fistula. Internal organs normally ...

Things you can do to help minimize gastroparesis’s effects on your life include: Diabetic gastroparesis prevents the stomach from emptying its contents at a normal speed, causing a variety of symptoms ...

Department of Hepatobiliary Surgery, Hebei International Joint Research Center for Digital Twin Diagnosis and Treatment of Digestive Tract Tumors, Baoding Key Laboratory of Precision Diagnosis and ...

Intermittent fasting, especially early fasting, helps with weight loss and improves heart health by reducing abdominal fat and regulating glucose. This safe method could be effective for managing ...

Intra-Cellular Therapies ITCI signed a definitive agreement with pharma bigwig Johnson & Johnson JNJ. Per the terms, the pharma giant will acquire all outstanding shares of ITCI for $132 per share ...

Mario Tama / Getty Images Shares of Intra-Cellular Therapies jumped Monday morning after Johnson & Johnson announced plans to buy the biopharmaceutical company. Intra-Cellular shareholders will ...